Rheumatic Toxicities Associated with Immune Checkpoint Inhibitors: An Observational, Retrospective, Pharmacovigilance Study

被引：0
|
作者：
Anquetil, Celine [1 ]
Benveniste, Olivier [1 ]
Moslehi, Javid [2 ]
Johnson, Douglas [2 ]
Lebrun-vignes, Benedicte [1 ]
Lambotte, Olivier [3 ,4 ,5 ,6 ]
Selam, Joe-Elie [1 ]
Spano, Jean-Philippe [1 ]
Allenbachl, Yves [1 ]
机构：
[1] Sorbonne Univ, Paris, France
[2] Vanderbilt, Nashville, TN USA
[3] Hop Bicetre, AP HP, Med Interne Immunol Clin, Paris, France
[4] Univ Paris Sud 11, Immunol Viral Infect & Autoimmune Dis, IDMIT Dept, INSERM,CEA,IBFJ,U1184, Fontenay Aux Roses, France
[5] Univ Paris Sud 11, Immunol Viral Infect & Autoimmune Dis, IDMIT Dept, INSERM,CEA,IBFJ,U1184, Le Kremlin Bicetre, France
[6] Univ Paris Sud 11, Immunol Viral Infect & Autoimmune Dis, IDMIT Dept, INSERM,CEA,IBFJ,U1184, Paris, France
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1810
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Combination of immune checkpoint inhibitors plus chemotherapy and risk of pneumonitis: A worldwide retrospective pharmacovigilance study.
    Zheng, Yi-Fan
    Xu, Pei-Hang
    Li, Zi-Mu
    Kuang, Yu-Kun
    Li, Jia
    He, Jun-Hao
    Chen, Xiao
    Tang, Ke-Jing
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [42] Dermatologic toxicities of immune checkpoint inhibitors
    Sibaud, V.
    Boulinguez, S.
    Pages, C.
    Riffaud, L.
    Lamant, L.
    Chira, C.
    Boyrie, S.
    Vigarios, E.
    Tournier, E.
    Meyer, N.
    [J]. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2018, 145 (05): : 313 - 330
  • [43] PREDICTORS OF RHEUMATIC TOXICITIES OF IMMUNE CHECKPOINT INHIBITORS AND CANCER OUTCOMES IN PATIENTS WITH ADVANCED MELANOMA
    Bruce, A.
    Menzies, A.
    Long, G.
    Fernandes, B.
    Joshua, F.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1818 - 1819
  • [44] Toxicities of immune checkpoint inhibitors and their management
    Kostine, Marie
    Marabelle, Aurelien
    Schaeverbeke, Thierry
    Kfoury, Maria
    [J]. M S-MEDECINE SCIENCES, 2020, 35 (12): : 949 - 956
  • [45] Endocrine toxicities of immune checkpoint inhibitors
    Jordan J. Wright
    Alvin C. Powers
    Douglas B. Johnson
    [J]. Nature Reviews Endocrinology, 2021, 17 : 389 - 399
  • [46] Managing toxicities of immune checkpoint inhibitors
    Broeckelmann, Paul
    Hassel, Jessica C.
    [J]. ONKOLOGIE, 2024, 30 (07): : 565 - 573
  • [47] Autoimmune Hematological Toxicities of Immune Checkpoint Inhibitors: A Real-World Pharmacovigilance Database Analysis
    Keerty, Dinesh
    Haddad, Philip A.
    Ramadas, Poornima
    Master, Samip R.
    [J]. BLOOD, 2022, 140 : 13160 - 13161
  • [48] Cardiovascular Toxicities of Antiangiogenic Tyrosine Kinase Inhibitors: A Retrospective, Pharmacovigilance Study
    Adam Goldman
    David Bomze
    Rachel Dankner
    Dana Fourey
    Ben Boursi
    Michael Arad
    Elad Maor
    [J]. Targeted Oncology, 2021, 16 : 471 - 483
  • [49] Rheumatic Complications of Immune Checkpoint Inhibitors
    Ghosh, Nilasha
    Bass, Anne R.
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2021, 105 (02) : 227 - 245
  • [50] Cardiovascular Toxicities of Antiangiogenic Tyrosine Kinase Inhibitors: A Retrospective, Pharmacovigilance Study
    Goldman, Adam
    Bomze, David
    Dankner, Rachel
    Fourey, Dana
    Boursi, Ben
    Arad, Michael
    Maor, Elad
    [J]. TARGETED ONCOLOGY, 2021, 16 (04) : 471 - 483
12345